Overview

The Study of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung Cancer

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
assess the efficacy and safety of gemcitabine in the maintenance treatment of advanced non-small cell lung cancer
Phase:
Phase 2
Details
Lead Sponsor:
Fudan University
Treatments:
Gemcitabine